– Talk will include case study on delivering personalization at scale
– Sharing experience based on 83bar 4-step Patient Activation process in trial recruitment
AUSTIN, Texas – Oct. 23, 2019 – PRLog — Kate Hermans, chief business officer for pharma at 83bar LLC, will present on driving patient empowerment at the 10th annual CNS Summit meeting October 31-November 3, 2019 in Boca Raton, Florida.
Ms. Hermans will deliver a talk to pharma and biotech R&D leaders, the top tech companies involved in clinical development and healthcare innovation, investigator sites, service companies, and regulators from FDA.
“83bar has developed a fully integrated digital health technology and concierge platform that enables individualized patient activation at scale,” says Ms. Hermans. “The use of the platform for clinical trial recruitment has shown meaningful results for study sponsors, investigator sites, and patients.”
The presentation will include a case study on why delivering personalization at scale is not only possible, but necessary.
Ms. Hermans will be featured on Saturday, November 2 during the CNS Summit Innovation Showcase sessions, which offer an opportunity for innovative emerging companies to present their novel products or services to forward-looking pharmaceutical leaders. The Innovation Showcase submissions are peer-reviewed and selected based on their level of innovation and novel approach to a challenge in clinical development.
About CNS Summit
CNS Summit is a platform for change and a community passionate about shaping the future, with a focus on collaboration, innovation, and technology. Our mission is to have a positive impact on the success of clinical development programs. We believe this mission is our ethical duty to the patients we serve by developing new treatments. Register at https://cnssummit.org/
About 83bar, LLC
83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system that has been implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of more than 850,000 patient engagements over the past three years. Its four-step activation process is a system integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment;